PubMed

Effectiveness of cholinesterase inhibitors and memantine for treating dementia: evidence review for a clinical practice guideline.

Raina P, Santaguida P, Ismaila A, Patterson C, Cowan D, Levine M, Booker L, Oremus M.

Ann Intern Med. 2008 Mar 4;148(5):379-97. Review.PMID: 18316756 [PubMed - indexed for MEDLINE]Related articlesFree article

Current pharmacologic treatment of dementia: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians.

Qaseem A, Snow V, Cross JT Jr, Forciea MA, Hopkins R Jr, Shekelle P, Adelman A, Mehr D, Schellhase K, Campos-Outcalt D, Santaguida P, Owens DK; American College of Physicians/American Academy of Family Physicians Panel on Dementia.

Ann Intern Med. 2008 Mar 4;148(5):370-8.PMID: 18316755 [PubMed - indexed for MEDLINE]Related articlesFree article

Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trials.

Kavirajan H, Schneider LS.

Lancet Neurol. 2007 Sep;6(9):782-92.PMID: 17689146 [PubMed - indexed for MEDLINE]Related articles

Clinical and cost-effectiveness of donepezil, rivastigmine and galantamine for Alzheimer's disease: a rapid and systematic review.

Clegg A, Bryant J, Nicholson T, McIntyre L, De Broe S, Gerard K, Waugh N.

Health Technol Assess. 2001;5(1):1-137. Review.PMID: 11262420 [PubMed - indexed for MEDLINE]Related articlesFree article

Summaries for patients. Drug treatment for patients with dementia: American College of Physicians and American Academy of Family Physicians recommendations.

[No authors listed]

Ann Intern Med. 2008 Mar 4;148(5):I41. No abstract available. PMID: 18316749 [PubMed - indexed for MEDLINE]Related articlesFree article

The clinical and cost-effectiveness of donepezil, rivastigmine, galantamine and memantine for Alzheimer's disease.

Loveman E, Green C, Kirby J, Takeda A, Picot J, Payne E, Clegg A.

Health Technol Assess. 2006 Jan;10(1):iii-iv, ix-xi, 1-160. Review.PMID: 16409879 [PubMed - indexed for MEDLINE]Related articlesFree article

Clinical and cost-effectiveness of donepezil, rivastigmine, and galantamine for Alzheimer's disease. A systematic review.

Clegg A, Bryant J, Nicholson T, McIntyre L, De Broe S, Gerard K, Waugh N.

Int J Technol Assess Health Care. 2002 Summer;18(3):497-507. Review.PMID: 12391943 [PubMed - indexed for MEDLINE]Related articles

A systematic review of the clinical effectiveness of donepezil, rivastigmine and galantamine on cognition, quality of life and adverse events in Alzheimer's disease.

Takeda A, Loveman E, Clegg A, Kirby J, Picot J, Payne E, Green C.

Int J Geriatr Psychiatry. 2006 Jan;21(1):17-28. Review.PMID: 16323253 [PubMed - indexed for MEDLINE]Related articles

Donepezil for mild and moderate Alzheimer's disease.

Birks J S, Melzer D.

Cochrane Database Syst Rev. 2000;(2):CD001190. Review. Update in: Cochrane Database Syst Rev. 2000;(4):CD001190. PMID: 10796620 [PubMed - indexed for MEDLINE]Related articles

Memantine for dementia.

Areosa SA, Sherriff F.

Cochrane Database Syst Rev. 2003;(3):CD003154. Review. Update in: Cochrane Database Syst Rev. 2004;(4):CD003154. PMID: 12917950 [PubMed - indexed for MEDLINE]Related articles

Are cholinesterase inhibitors effective in the management of the behavioral and psychological symptoms of dementia in Alzheimer's disease? A systematic review of randomized, placebo-controlled trials of donepezil, rivastigmine and galantamine.

Rodda J, Morgan S, Walker Z.

Int Psychogeriatr. 2009 Oct;21(5):813-24. Epub 2009 Jun 19. Review.PMID: 19538824 [PubMed - indexed for MEDLINE]Related articles

Evidence-based pharmacotherapy of Alzheimer's disease.

Evans JG, Wilcock G, Birks J.

Int J Neuropsychopharmacol. 2004 Sep;7(3):351-69. Epub 2004 Jul 1. Review.PMID: 15228642 [PubMed - indexed for MEDLINE]Related articles

[Clinical efficacy and safety of akatinol memantine in treatment of mild to moderate Alzheimer disease: a donepezil-controlled, randomized trial]

Hu HT, Zhang ZX, Yao JL, Yu HZ, Wang YH, Tang HC, Ji CJ, Xu T.

Zhonghua Nei Ke Za Zhi. 2006 Apr;45(4):277-80. Chinese. PMID: 16780671 [PubMed - indexed for MEDLINE]Related articles

[Retrospective comparative analysis of antidementia medication persistence patterns in Spanish Alzheimer's disease patients treated with donepezil, rivastigmine, galantamine and memantine]

Sicras-Mainar A, Vergara J, Leon-Colombo T, Febrer L, Rejas-Gutierrez J.

Rev Neurol. 2006 Oct 16-31;43(8):449-53. Spanish. PMID: 17033976 [PubMed - indexed for MEDLINE]Related articlesFree article

Cholinesterase inhibitors for patients with Alzheimer's disease: systematic review of randomised clinical trials.

Kaduszkiewicz H, Zimmermann T, Beck-Bornholdt HP, van den Bussche H.

BMJ. 2005 Aug 6;331(7512):321-7. Review.PMID: 16081444 [PubMed - indexed for MEDLINE]Related articlesFree article

Drug therapy of dementia in elderly patients. A review.

Olsen CE, Poulsen HD, Lublin HK.

Nord J Psychiatry. 2005;59(2):71-7. Review.PMID: 16195103 [PubMed - indexed for MEDLINE]Related articles

Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial.

Tariot PN, Farlow MR, Grossberg GT, Graham SM, McDonald S, Gergel I; Memantine Study Group.

JAMA. 2004 Jan 21;291(3):317-24.PMID: 14734594 [PubMed - indexed for MEDLINE]Related articlesFree article

Tolerability of memantine in combination with cholinesterase inhibitors in dementia therapy.

Hartmann S, Möbius HJ.

Int Clin Psychopharmacol. 2003 Mar;18(2):81-5.PMID: 12598818 [PubMed - indexed for MEDLINE]Related articles

Cholinesterase inhibitors in mild cognitive impairment: a systematic review of randomised trials.

Raschetti R, Albanese E, Vanacore N, Maggini M.

PLoS Med. 2007 Nov 27;4(11):e338. Review.PMID: 18044984 [PubMed - indexed for MEDLINE]Related articlesFree article

Clinical practice with anti-dementia drugs: a consensus statement from British Association for Psychopharmacology.

Burns A, O'Brien J; BAP Dementia Consensus group, Auriacombe S, Ballard C, Broich K, Bullock R, Feldman H, Ford G, Knapp M, McCaddon A, Iliffe S, Jacova C, Jones R, Lennon S, McKeith I, Orgogozo JM, Purandare N, Richardson M, Ritchie C, Thomas A, Warner J, Wilcock G, Wilkinson D; British Association for Psychopharmacology.

J Psychopharmacol. 2006 Nov;20(6):732-55. Review.PMID: 17060346 [PubMed - indexed for MEDLINE]Related articles